ASX - By Stock
|
IMM |
Re:
What have we got?
|
|
georges
|
49 |
34K |
16 |
26/06/24 |
26/06/24 |
ASX - By Stock
|
49
|
34K
|
16
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Half Yearly Report and Accounts
|
|
georges
|
14 |
5.0K |
1 |
02/03/23 |
02/03/23 |
ASX - By Stock
|
14
|
5.0K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 4C - quarterly
|
|
georges
|
268 |
85K |
9 |
01/08/18 |
01/08/18 |
ASX - By Stock
|
268
|
85K
|
9
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Admedus contracts with US Group Purchasing Organisation
|
|
georges
|
74 |
28K |
9 |
09/03/18 |
09/03/18 |
ASX - By Stock
|
74
|
28K
|
9
|
|
ASX - By Stock
|
VLA |
Re:
Ann: Ceasing to be a substantial holder
|
|
georges
|
16 |
7.8K |
5 |
12/01/18 |
12/01/18 |
ASX - By Stock
|
16
|
7.8K
|
5
|
|
ASX - By Stock
|
VLA |
Chairmans Address
|
|
georges
|
1 |
571 |
3 |
22/11/17 |
22/11/17 |
ASX - By Stock
|
1
|
571
|
3
|
|
ASX - By Stock
|
VLA |
Amgen results - great for VLA
|
|
georges
|
6 |
3.8K |
13 |
04/06/17 |
04/06/17 |
ASX - By Stock
|
6
|
3.8K
|
13
|
|
ASX - By Stock
|
VLA |
FierceBiotech article
|
|
georges
|
0 |
1.0K |
11 |
22/11/16 |
22/11/16 |
ASX - By Stock
|
0
|
1.0K
|
11
|
|
ASX - By Stock
|
VLA |
Re:
Ann: Change of Directors Interest Notice
|
|
georges
|
23 |
6.1K |
9 |
16/11/16 |
16/11/16 |
ASX - By Stock
|
23
|
6.1K
|
9
|
|
ASX - By Stock
|
VLA |
Re:
Voting - Resolution 8
|
|
georges
|
14 |
3.8K |
12 |
25/10/16 |
25/10/16 |
ASX - By Stock
|
14
|
3.8K
|
12
|
|
ASX - By Stock
|
VLA |
Re:
Roth Report
|
|
georges
|
58 |
22K |
13 |
02/05/16 |
02/05/16 |
ASX - By Stock
|
58
|
22K
|
13
|
|
ASX - By Stock
|
VLA |
Enormous $9.8b phase II cancer deal
|
|
georges
|
9 |
2.8K |
4 |
29/04/16 |
29/04/16 |
ASX - By Stock
|
9
|
2.8K
|
4
|
|
ASX - By Stock
|
VLA |
Interesting article
|
|
georges
|
1 |
1.2K |
12 |
22/03/16 |
22/03/16 |
ASX - By Stock
|
1
|
1.2K
|
12
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Admedus appoints new Chairman
|
|
georges
|
66 |
21K |
2 |
10/02/16 |
10/02/16 |
ASX - By Stock
|
66
|
21K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Admedus appoints new Chairman
|
|
georges
|
66 |
21K |
6 |
09/02/16 |
09/02/16 |
ASX - By Stock
|
66
|
21K
|
6
|
|
ASX - By Stock
|
VLA |
Australian cancer drug licensed for $0.7billion
|
|
georges
|
3 |
1.5K |
4 |
04/02/16 |
04/02/16 |
ASX - By Stock
|
3
|
1.5K
|
4
|
|
ASX - By Stock
|
VLA |
Re:
Merck on the prowl for new drugs
|
|
georges
|
8 |
2.7K |
22 |
07/01/16 |
07/01/16 |
ASX - By Stock
|
8
|
2.7K
|
22
|
|
ASX - By Stock
|
VLA |
Re:
Keytruda and TVec combination results presentation
|
|
georges
|
31 |
11K |
6 |
19/11/15 |
19/11/15 |
ASX - By Stock
|
31
|
11K
|
6
|
|
ASX - By Stock
|
VLA |
Re:
Keytruda and TVec combination results presentation
|
|
georges
|
31 |
11K |
4 |
19/11/15 |
19/11/15 |
ASX - By Stock
|
31
|
11K
|
4
|
|
ASX - By Stock
|
VLA |
Keytruda and TVec combination results presentation
|
|
georges
|
31 |
11K |
5 |
18/11/15 |
18/11/15 |
ASX - By Stock
|
31
|
11K
|
5
|
|
ASX - By Stock
|
VLA |
Re:
Ann: Viralytics and Merck Collaborate in Lung and Bladder Cancer
|
|
georges
|
36 |
8.0K |
8 |
06/11/15 |
06/11/15 |
ASX - By Stock
|
36
|
8.0K
|
8
|
|
ASX - By Stock
|
VLA |
Re:
Another Billion Dollar Deal
|
|
georges
|
1 |
776 |
5 |
16/10/15 |
16/10/15 |
ASX - By Stock
|
1
|
776
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Positive CardioCel valve reconstruction data
|
|
georges
|
117 |
34K |
5 |
09/10/15 |
09/10/15 |
ASX - By Stock
|
117
|
34K
|
5
|
|
ASX - By Stock
|
VLA |
Life sciences VLA article
|
|
georges
|
2 |
2.1K |
21 |
23/07/15 |
23/07/15 |
ASX - By Stock
|
2
|
2.1K
|
21
|
|
ASX - By Stock
|
VLA |
Value of a company in a takover
|
|
georges
|
6 |
2.7K |
6 |
29/06/15 |
29/06/15 |
ASX - By Stock
|
6
|
2.7K
|
6
|
|
ASX - By Stock
|
VLA |
Re:
Ann: VLA to Present CAVATAK Bladder and Other Results at Conf.
|
|
georges
|
105 |
33K |
3 |
11/06/15 |
11/06/15 |
ASX - By Stock
|
105
|
33K
|
3
|
|
ASX - By Stock
|
VLA |
Re:
Ann: Positive final results from CAVATAK Phase 2 Melanoma Trial
|
|
georges
|
102 |
30K |
3 |
02/06/15 |
02/06/15 |
ASX - By Stock
|
102
|
30K
|
3
|
|
ASX - By Stock
|
VLA |
Re:
Combination trials - good news
|
|
georges
|
35 |
10K |
5 |
30/05/15 |
30/05/15 |
ASX - By Stock
|
35
|
10K
|
5
|
|
ASX - By Stock
|
VLA |
Combination trials - good news
|
|
georges
|
35 |
10K |
4 |
30/05/15 |
30/05/15 |
ASX - By Stock
|
35
|
10K
|
4
|
|
ASX - By Stock
|
VLA |
Re:
VLA versus T-Vec
|
|
georges
|
13 |
3.9K |
3 |
25/05/15 |
25/05/15 |
ASX - By Stock
|
13
|
3.9K
|
3
|
|
ASX - By Stock
|
VLA |
Re:
VLA versus T-Vec
|
|
georges
|
13 |
3.9K |
4 |
25/05/15 |
25/05/15 |
ASX - By Stock
|
13
|
3.9K
|
4
|
|
ASX - By Stock
|
VLA |
Re:
Ann: VLA to present final CALM Clinical Data at ASCO 2015
|
|
georges
|
123 |
35K |
6 |
14/05/15 |
14/05/15 |
ASX - By Stock
|
123
|
35K
|
6
|
|
ASX - By Stock
|
VLA |
Re:
Ann: VLA to present final CALM Clinical Data at ASCO 2015
|
|
georges
|
123 |
35K |
4 |
14/05/15 |
14/05/15 |
ASX - By Stock
|
123
|
35K
|
4
|
|
ASX - By Stock
|
VLA |
Re:
Bioshares Report
|
|
georges
|
4 |
1.7K |
1 |
06/05/15 |
06/05/15 |
ASX - By Stock
|
4
|
1.7K
|
1
|
|
ASX - By Stock
|
AVR |
Demerger
|
|
georges
|
0 |
420 |
5 |
01/05/15 |
01/05/15 |
ASX - By Stock
|
0
|
420
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Quarterly
|
|
georges
|
174 |
56K |
9 |
01/05/15 |
01/05/15 |
ASX - By Stock
|
174
|
56K
|
9
|
|
ASX - By Stock
|
VLA |
Re:
T-Vec FDA Advisory comm meeting 22 YES 1 NO
|
|
georges
|
30 |
8.1K |
8 |
30/04/15 |
30/04/15 |
ASX - By Stock
|
30
|
8.1K
|
8
|
|
ASX - By Stock
|
VLA |
Yervoy - future deal: Amgne not that important
|
|
georges
|
4 |
1.6K |
5 |
29/04/15 |
29/04/15 |
ASX - By Stock
|
4
|
1.6K
|
5
|
|
ASX - By Stock
|
VLA |
IV results - great results
|
|
georges
|
4 |
1.7K |
15 |
23/04/15 |
23/04/15 |
ASX - By Stock
|
4
|
1.7K
|
15
|
|
ASX - By Stock
|
VLA |
Re:
Novogen results
|
|
georges
|
25 |
9.1K |
25 |
16/04/15 |
16/04/15 |
ASX - By Stock
|
25
|
9.1K
|
25
|
|
ASX - By Stock
|
VLA |
Re:
Ann: VLA to present CAVATAK clinical data at AACR Annual Meeting
|
|
georges
|
16 |
6.1K |
8 |
19/03/15 |
19/03/15 |
ASX - By Stock
|
16
|
6.1K
|
8
|
|
ASX - By Stock
|
VLA |
Re:
Market Cap Value
|
|
georges
|
49 |
13K |
5 |
06/03/15 |
06/03/15 |
ASX - By Stock
|
49
|
13K
|
5
|
|
ASX - By Stock
|
VLA |
Re:
Market Cap Value
|
|
georges
|
49 |
13K |
3 |
05/03/15 |
05/03/15 |
ASX - By Stock
|
49
|
13K
|
3
|
|
ASX - By Stock
|
VLA |
Re:
agm - company direction and focus
|
|
georges
|
10 |
681 |
2 |
26/11/12 |
26/11/12 |
ASX - By Stock
|
10
|
681
|
2
|
|
ASX - By Stock
|
VLA |
Re:
shafted!
|
|
georges
|
32 |
1.5K |
2 |
23/11/12 |
23/11/12 |
ASX - By Stock
|
32
|
1.5K
|
2
|
|
ASX - By Stock
|
VLA |
Re:
Ann: Viralytics receives $1.467m R&D tax concessi
|
|
georges
|
13 |
705 |
2 |
13/11/12 |
13/11/12 |
ASX - By Stock
|
13
|
705
|
2
|
|
ASX - By Stock
|
VLA |
Re:
Ann: Viralytics receives $1.467m R&D tax concessi
|
|
georges
|
13 |
705 |
9 |
13/11/12 |
13/11/12 |
ASX - By Stock
|
13
|
705
|
9
|
|